subject area of
- A Prospective Randomized Study of Alpha-2b Interferon plus Hydroxyurea or Cytarabine for Patients with Early Chronic Phase Chronic Myelogenous Leukemia: The International Oncology Study Group CML1 Study Academic Article
- A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia Academic Article
- A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over Academic Article
- A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186 Academic Article
- A phase I?II study of combination therapy with thymidine and cytosine arabinoside Academic Article
- AML refractory to primary induction with Ida-FLAG has a poor clinical outcome Academic Article
- Adjuvant chemotherapy with CEF versus CMF for node-positive breast cancer. Academic Article
- Cell cycle and drug sensitivity studies of leukemic cells that appear relevant in determining response to chemotherapy in acute nonlymphocytic leukemia. Academic Article
- Changes in the characteristics of the bone marrow during therapy for acute non-lymphocytic leukemia: Relationship to response to remission induction therapy Academic Article
- Clinical and prognostic significance of in vivo differentiation in acute myeloid leukemia Academic Article
- Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial Academic Article
- Clinical evidence of a cumulative effect of high-dose cytarabine on the cerebellum in patients with acute leukemia: a leukemia intergroup report. Academic Article
- Cost-effectiveness analysis of rituximab with methotrexate, cytarabine and thiotepa for the treatment of patients with primary central nervous system lymphoma Academic Article
- Cost-effectiveness of a Transplantation Strategy Compared to Melphalan and Prednisone in Younger Patients with Multiple Myeloma Academic Article
- Cytarabine-induced palmar-plantar erythema Academic Article
- Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: a leukemia intergroup study Academic Article
- Drug-Induced Stomatocytosis and Anemia During Consolidation Chemotherapy of Childhood Acute Leukemia Academic Article
- Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12 Academic Article
- Herpes encephalitis. Academic Article
- High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study. Academic Article
- High-dose cytosine arabinoside in the treatment of preleukemic disorders: A leukemia intergroup study Academic Article
- High-dose cytosine arabinoside: Clinical response to therapy in acute leukemia Academic Article
- INDs for PET Molecular Imaging Probes—Approach by an Academic Institution Academic Article
- Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells Academic Article
- Induction of fragility at the human RNU2 locus by cytosine arabinoside is dependent upon a transcriptionally competent U2 small nuclear RNA gene and the expression of p53 Academic Article
- Inhibition of DNA synthesis by cytosine arabinoside: Relation to response of acute non-lymphocytic leukemia to remission induction therapy and to stage of the disease Academic Article
- Interleukin-1 beta expression and treatment outcome in acute myelogenous leukemia [letter] Academic Article
- Limited efficacy of a four-day course of high-dose cytosine arabinoside in the treatment of poor-risk patients with acute nonlymphocytic leukemia Academic Article
- Long Term Outcome of Patients with Acute Myelogenous Leukemia: The Role of Maintenance Therapy, Consolidation Therapy and the Predictive Value of Twoin vitroAssays Academic Article
- Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia Academic Article
- Management of Children with Acute Lymphoblastic Leukemia by the Dana-Farber Cancer Institute Protocols Academic Article
- Neuropsychological Outcomes From a Randomized Trial of Triple Intrathecal Chemotherapy Compared With 18 Gy Cranial Radiation As CNS Treatment in Acute Lymphoblastic Leukemia: Findings From Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 Academic Article
- Potentiation of chlorambucil toxicity in B-CLL lymphocytes using the DNA synthesis inhibitors aphidicolin and 1-β-d-arabinofuranosylcytosine Academic Article
- Predicting remission outcome in acute non-lymphocytic leukemia: General principles and their application to residual marrow leukemia Academic Article
- Prediction of response of acute nonlymphocytic leukaemia to therapy with ‘high dose’ cytosine arabinoside Academic Article
- Prediction of response of patients with acute nonlymphocytic leukaemia to remission induction therapy: use of clinical measurements Academic Article
- Predictors and Outcomes of Viridans Group Streptococcal Infections in Pediatric Acute Myeloid Leukemia Academic Article
- Progressive multifocial leukoencephalopathy in a child with immunodeficiency and hyperimmunoglobulinemia M Academic Article
- Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12 Academic Article
- Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup Study. Academic Article
- Real-World Treatment Patterns and Clinical Outcomes in Canadian Patients with AML Unfit for First-Line Intensive Chemotherapy Academic Article
- Recurrent palmar–plantar erythrodysaesthesia following high‐dose cytarabine treatment for acute lymphoblastic leukemia Academic Article
- Relation between platinum-DNA adducts and complete remission in adult acute nonlymphocytic leukemia Academic Article
- Relationship between the per cent of marrow cells in S phase and the outcome of remission-induction therapy for acute nonlymphocytic leukaemia Academic Article
- Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study. Academic Article
- Remissions after third induction chemotherapy for primary non-responders with acute myeloid leukemia (AML) are uncommon and short-lived Academic Article
- Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial Academic Article
- Risk of Acute Leukemia Following Epirubicin-Based Adjuvant Chemotherapy: A Report From the National Cancer Institute of Canada Clinical Trials Group Academic Article
- Risk of Menopause During the First Year After Breast Cancer Diagnosis Academic Article
- Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study Academic Article
- Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12 Academic Article
- Selection and management of older patients with acute myeloid leukemia treated with glasdegib plus low-dose cytarabine: expert panel review Academic Article
- Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells Academic Article
- Studies in mouse L-cells on the incorporation of 1-beta-D-arabinofuranosylcytosine into DNA and on inhibition of DNA polymerase by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate. Academic Article
- Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy Academic Article
- The clonogenic assay as a reproducible in vitro system to study predictive parameters of treatment outcome in acute nonlymphoblastic leukemia Academic Article
- The effect of-beta-D-arabinofuranosylcytosine on growth, viability, and DNA synthesis of mouse L-cells. Academic Article
- The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup Study Academic Article
- The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation Academic Article
- The treatment of acute myelocytic leukemia in patients 30 years of age and younger Academic Article
- The treatment of patients with acute nonlymphocytic leukemia in remission. Academic Article
- The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failure Academic Article
- Therapy of Secondary Acute Nonlymphocytic Leukemia Academic Article
- Therapy of Secondary Acute Nonlymphocytic Leukemia with Cytarabine Academic Article
- Treatment of patients with acute nonlymphocytic leukemia in relapse: A leukemia intergroup study Academic Article
- Treatment of the Chronic Phase of Chronic Myeloid Leukemia with an Intermittent Schedule of Recombinant Interferon Alfa-2b and Cytarabine: Results from CALGB Study 9013 Conference Paper
- Use of the day 6 bone marrow to alter remission induction therapy in patients with acute myeloid leukaemia: a leukemia intergroup study Academic Article